Drug Profile
PDI 29
Alternative Names: PDI29Latest Information Update: 28 Jan 2019
Price :
$50
*
At a glance
- Originator Ache Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Constipation
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for research development in Constipation in Brazil
- 31 Dec 2014 Early research in Constipation in Brazil (unspecified route) prior to December (Ache's annual report,